Congenital Hematological Disorder Enrolling by Invitation Phase Trials for Catridecacog (DB09310)

Also known as: Congenital bleeding disorders / Congenital Bleeding Disorder / Congenital haematological disorder

IndicationStatusPhase
DBCOND0081791 (Congenital Hematological Disorder)Enrolling by InvitationNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02670213A Study of Safety and Effectiveness of NovoThirteenĀ® (rFXIII) During Treatment of Congenital FXIII Deficiency in Japan